Brief: Transcode Therapeutics Appoints Zdravka Medarova As Chief Technology Officer
30/09/2021 21:09
Sept 30 (Reuters) - Transcode Therapeutics Inc RNAZ.O :
* TRANSCODE THERAPEUTICS APPOINTS ZDRAVKA MEDAROVA, PH.D.,
AS
CHIEF TECHNOLOGY OFFICER
Source text for Eikon: ID:nBw6xjBvDa
Further company coverage: RNAZ.O
Recent news on Transcode Therapeutics
See all newsBrief: TransCode Therapeutics Appoints John Tattory As Interim CFO
Brief: Transcode Therapeutics Appoints Dr. Anna Moore As Chair Of Scientific Advisory Board
Brief: Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash
Brief: Transcode Therapeutics Ttx-Mc138 Phase 2A Clinical Trial Expected In First Half Of 2026
Brief: Transcode Therapeutics Expands Leadership With Appointment Of Jack E. Stover To Board Of Directors